4581 — Taisho Pharmaceutical Holdings Co Income Statement
0.000.00%
Last trade - 00:00- ¥704bn
- ¥463bn
- ¥301bn
- 72
- 35
- 96
- 82
Annual income statement for Taisho Pharmaceutical Holdings Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2019 March 31st | R2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 261,551 | 288,527 | 281,980 | 268,203 | 301,381 |
| Cost of Revenue | |||||
| Gross Profit | 170,345 | 180,141 | 175,930 | 163,832 | 177,850 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 249,608 | 261,888 | 264,419 | 258,412 | 279,930 |
| Operating Profit | 11,943 | 26,639 | 17,561 | 9,791 | 21,451 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 64,484 | 29,775 | 22,976 | 21,398 | 29,498 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 49,826 | 21,530 | 15,194 | 14,950 | 21,302 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 48,595 | 20,174 | 13,316 | 13,122 | 18,997 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 48,592 | 20,170 | 13,315 | 13,122 | 18,997 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 395 | 271 | 283 | 265 | 340 |
| Dividends per Share | |||||
| Special Dividends per Share |